New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 21, 2014
07:37 EDTEWEdwards Lifesciences price target raised to $96 from $86 at Canaccord
Canaccord raised its price target on Edwards Lifesciences (EW) to $96 based on the worldwide patent litigation settlement with Medtronic (MDT). The firm believes the agreement removes an expensive distraction for the business and retains the goodwill of physicians. Shares are Buy rated.
News For EW From The Last 14 Days
Check below for free stories on EW the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2014
08:16 EDTEWEdwards Lifesciences price target raised to $103 from $96 at Canaccord
Subscribe for More Information
July 29, 2014
18:35 EDTEWOn The Fly: After Hours Movers
Subscribe for More Information
16:18 EDTEWEdwards Lifesciences sees Q3 EPS 66c-72c, consensus 74c
Subscribe for More Information
16:17 EDTEWEdwards Lifesciences raises 2014 EPS outlook to $3.24-$3.34, consensus $3.19
Subscribe for More Information
16:16 EDTEWEdwards Lifesciences reports Q2 EPS 88c, consensus 77c
Reports Q2 revenue $575.1M, consensus $544.3M.
15:53 EDTEWNotable companies reporting after market close
Subscribe for More Information
July 28, 2014
11:07 EDTEWLeerink medical devices analyst holds an analyst/industry conference call
Medical Devices Analyst Antalffy, along with MEDACorp Specialist Arie Pieter Kappetein, MD, PhD and Bernhard Meier, MD, assess EU cardiology trends on an Analyst/Industry conference call to be held on July 31 at 3 pm.
July 22, 2014
07:57 EDTEWHouse Energy & Commerce Committee to hold a hearing
The Subcommittee on Health holds a hearing entitled, "21st Century Cures: Examining Barriers to Ongoing Evidence Development and Communication" with CEO Mussallem at Edwards Lifesciences on July 22 at 3 pm. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use